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PharmacovigilancePharmacovigilance (PV) is defined by the World Health Organization as the science and activities related
to the detection, assessment, understanding and prevention of adverse effects or any other drug-related
problem. An essential aspect in PV is to acquire knowledge about Drug–Drug Interactions (DDIs). The
shared tasks on DDI-Extraction organized in 2011 and 2013 have pointed out the importance of this issue
and provided benchmarks for: Drug Name Recognition, DDI extraction and DDI classification. In this
paper, we present our text mining systems for these tasks and evaluate their results on the
DDI-Extraction benchmarks. Our systems rely on machine learning techniques using both
feature-based and kernel-based methods. The obtained results for drug name recognition are encourag-
ing. For DDI-Extraction, our hybrid system combining a feature-based method and a kernel-based
method was ranked second in the DDI-Extraction-2011 challenge, and our two-step system for DDI
detection and classification was ranked first in the DDI-Extraction-2013 task at SemEval. We discuss
our methods and results and give pointers to future work.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Drug–Drug Interaction (DDI) is a condition when one drug
influences the level or activity of another drug. Acquiring knowl-
edge of DDIs has significant importance for both patient safety
and efficient health care management. It was reported that about
2.2 million people in USA, age 57–85, were taking potentially dan-
gerous combinations of drugs [23]. It was also estimated that
deaths from accidental drug interactions rose by 68% in a 5-years
period between 1999 and 2004 [30]. The interactions between
drugs can also increase the risk of side effects, and their number
was shown to be correlated to the number of drugs taken by each
patient [20]. However, with the rapid growth of drug industries
and the exponential number of possible combinations, keepingstrong insights on DDIs is becoming a more and more challenging
task.
Biomedical literature and clinical reports provide a natural
ground to detect and analyze DDIs at a big scale. However making
use of such huge quantity of information requires the design of
efficient and automatic tools that can assist human experts in
the discovery and follow-up of DDIs. The DDI-Extraction-2011
and DDI-Extraction-2013 shared tasks particularly underlined the
importance of the extraction of DDIs from medical texts.
Recognizing DDIs from medical texts requires (i) identifying
drug mentions, (ii) detecting the expressions that indicate interac-
tions between the mentioned drugs, and (iii) classifying of the
interactions according to their types. In this paper we present three
approaches to tackle these tasks:
 A feature-based approach for drug name recognition, evaluated
on the DDI-2013 corpus for Task 9.1: Drug name recognition.
 A hybrid approach for DDI detection [6], combining a feature-
based method and a kernel-based method, evaluated on the
DDI-2011 corpus.
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which is basically a considerable improvement on the kernel
method mentioned above. This approach was evaluated both
on the DDI-2013 corpus for Task 9.2: Extraction of drug–drug
interactions and on the DDI-2011 corpus.
In the following we first survey research works related to the
above three tasks. We then present our approaches in Sections
3–5. The results on the data sets of the DDI-Extraction-2011 and
DDI-Extraction-2013 challenges are described in Sections 6 and 7
respectively. We finally conclude with pointers to future work in
Section 8.
2. Related works
Several approaches have been proposed for the recognition of
medical entities such as diseases, treatments and exams [2]. Other
efforts tackled the extraction of specific entities such as drugs. For
instance, the 2009 i2b2 challenge1 focused on the extraction of
medication-related information (e.g. medication name, dosage, fre-
quency, mode of administration) from narrative patient records.
Several approaches have also studied the recognition of chemical
entities (i.e. chemical compounds and drugs). Grego et al. [17]
proposed a chemical entity recognition approach using Conditional
Random Fields for identifying chemical terms and lexical similarity
for the classification of entities according to the ChEBI ontology. They
participated to the SemEval-2013 challenge on the recognition and
classification of drug names (Task 9.1) and obtained a macro-
average F1 score of 0.577 on the full dataset (DrugBank andMedline).
Rocktäschel et al. [31] studied the impact of domain-specific
features on the task of recognizing and classifying mentions of
pharmacological substances. They used predictions of their
improved version of the ChemSpot tool2 [32] and features derived
from (i) Jochem,3 a dictionary for the identification of small mole-
cules and drugs in text [18], (ii) the PHARE ontology [14] and (iii)
the ChEBI ontology [25]. Their system was ranked first in the
SemEval-2013 Task 9.1 with a macro-average F1 score of 0.652 on
the whole dataset (MedLine and DrugBank).
Besides the recognition of textual mentions of medical entities,
the detection and classification of (bio) medical relations is an
important task that was addressed by many research works [1].
For instance, Song et al. [37] proposed a protein–protein inter-
action (PPI) extraction technique called PPISpotter that combines
an active learning technique with semi-supervised Support Vector
Machines (SVM) to extract protein–protein interaction. Chen et al.
[5] proposed a PPI Pair Extractor (PPIEor), based on a SVM for
binary classification which uses a linear kernel and a rich set of fea-
tures based on linguistic analysis, contextual words, interaction
words, interaction patterns and specific domain information. Li
et al. [24] use an ensemble kernel to extract the PPI information.
This ensemble kernel consists of a feature-based kernel and a
structure-based kernel using the parse trees of the sentences
containing at least two protein names.
Other approaches particularly focused on the extraction of DDI.
Segura-Bedmar et al. [34] compared two different approaches for
the extraction of DDIs from texts: (i) a hybrid linguistic approach
that combines shallow parsing and pattern matching and (ii) a
kernel-based approach that uses SVM presented by Giuliano et al.
[16]. For the evaluation, they created and annotated the first corpus
annotatedwith DDIs containing 579 documents from the DrugBank
database and a total of 3160 DDIs. The lexical patterns achieve1 https://www.i2b2.org/NLP/Medication/.
2 https://www.informatik.hu-berlin.de/forschung/gebiete/wbi/resources/chem-
spot/chemspot/.
3 http://biosemantics.org/index.php?page=Jochem.67.30%precisionand14.07% recall.With the inclusionof appositions
and coordinate structures they obtained 48.69% precision and
25.70% recall. The second approach based on kernel-methods
achieves better performance with 55.1% precision and 82.3% recall.
Also, different machine learning approaches were proposed
within the DDI-Extraction challenges in 2011 and 2013. In [36], the
authors observed that in the 2013 DDI-Extraction task non-linear
kernel-based methods outperformed linear SVM-based approaches.
In this paper, we describe our experience from the participation
in the 2011 and 2013 DDI-Extraction tasks, and analyze the results
obtained by (i) our hybrid system for DDI detection [6] which com-
bines feature-based and kernel-based methods (Sections 4 and 6)
and (ii) our two-step approach for the detection and classification
of DDIs [12] (Sections 5 and 7.3). We also present our new approach
for drug name recognition in Section 3 and evaluate it on the DDI-
Extraction-2013 corpus in Section 7.2.
3. Feature-based method for drug name recognition
Drug recognition frommedical texts involves twomain tasks: (i)
identification ofmentionsboundaries in the sentences and (ii) entity
classification. In the context of the DDI-Extraction-2013 challenge,
four classeswere considered for the task of the recognition and clas-
sification of drug names: Drug, Drug_n, Brand and Group (cf. Sec-
tion 7.2 for the description of each category). We proposed and
evaluated a feature-based method using the Conditional Random
Fields (CRF) algorithm and several linguistic and semantic features.
In the following section we present the main characteristics of the
CRF algorithm and its application in the scope of the challenge. In
Sections 3.2 and 3.3we present the final set of linguistic and seman-
tic features that we selected to train the CRF-based classifier.
3.1. CRF algorithm
Words in a sentence form a sequence and the decision on a
word’s category can be influenced by the decision on the category
of the preceding word. This dependency is taken into account in
sequential models such as Hidden Markov Models (HMM) or Con-
ditional Random Fields (CRF). In contrast with HMM, CRF learning
maximizes the conditional probability of classes with respect to
observations rather than their joint probability. This makes it pos-
sible to use any number of features which may be related to all
aspects of the input sequence of words. These properties are assets
of CRF for several NLP tasks, such as POS tagging, noun phrase
chunking, or named entity recognition.
We use the CRF learning algorithm [22] in order to annotate the
words with BIO (Beginning-Inside-Outside) labels. Given n entity
types (e.g. Drug,Drug_n, Brand,Group),we considern classes of type
‘B’ and n classes of type ‘I’. The B_Entity_Type represents the first
word of a pharmacological entity, I_Entity_Type represents the
remainingwords of the pharmacological entity and theO represents
the words that are not terms of a pharmacological entity. For
instance, the words of the following sentence will be annotated as:
‘‘Studies(O) have(O) shown(O) that(O) TIKOSYN(B-Drug)
does(O) not(O) affect(O) the(O) pharmacokinetics(O) of(O)
oral(B-Drug) contraceptives(I-Drug)”.
According to [26], suppose x ¼ fx1; x2; x3; . . . ; xTg is a set of input
values (e.g. a sequence of words) and s ¼ fs1; s2; s3; . . . ; sTg is a set of
states that are assigned tonamedentity labels, CRFestimates the con-
ditional probability of a state sequence given an input sequence as
follows:
PðsjxÞ ¼ 1
Z
exp
XT
t¼1
XK
k¼1
kkf kðst1; st ; x; tÞ
 !
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the word positions, 1; . . . ;K represent the positions of the weighted
features, the f k represents the feature function and the kk is the
weight of each feature function.
We use the CRF++4 tool for constructing probabilistic models
over the training data in order to predict the entity type of tokens
in the test data. We use the values of several features as an input
set of observations (e.g. words, lemmas, POS-tag, length of words).
The final list of features is presented in the following sections.
3.2. Token and linguistic features
Token features:
 The original form and the lemma of the current word.
 Two tokens after and two tokens before the current word
and their lemmas.
Linguistic features:
 The part-of-speech tag (POS-tag) of the current word, its
preceding two words and its following two words.
 The length of the current word, of the previous word and
of the two following words.
 The suffix of the current word (3 last characters).
Binary features indicating whether:
 The current word is a number.
 The current word and the previous word are composed by
alphabetic characters only.
 The current word, the previous word and the next word
begin with a capital letter.
 The current word and the two previous words are all
capitalized and without digits.
 The current word, the two previous words and the next
word have length equal to 2.
 The current word has lower letters mixed with capital
letters and does not contain digits.
 The currentword and the nextword contain a forward slash.
3.3. Semantic features
 Several binary features are defined to indicate the pres-
ence/absence of a word in a specific list. The considered
lists are: a stop words list,5 a list of abbreviations6 and a list
of medical units of measurement.7
 A list of drugs, taken from drugs@FDA8 is used to tag the
current word, the two previous words and the next word
as a Drug. More precisely, the BIO format is used to anno-
tate the words: B-Drug for the first word of a drug name,
I-Drug for the words inside a drug name and O for the words
that are not in the list of drugs.
 A list of drugs’ ingredients, taken from RxTerms-drug
interface terminology,9 is used to annotate the current
word as an Ingredient. Similarly to the previous annotation
method, the words of medical texts are annotated using the
BIO format: B-Ingredient for the first word of an ingredient4 http://crfpp.googlecode.com/svn/trunk/doc/index.html.
5 http://www.ranks.nl/stopwords.
6 http://en.wikipedia.org/wiki/List_of_medical_abbreviations.
7 http://www.mayomedicallaboratories.com/test-catalog/appendix/measurement.
html.
8 http://www.accessdata.fda.gov/scripts/cder/drugsatfda.
9 https://wwwcf.nlm.nih.gov/umlslicense/rxtermApp/rxTermFileStructure.cfm.name, I-Ingredient for the words inside an ingredient name
and O for the words that are not contained in the list of
ingredients.
The evaluation of our Drug Name Recognition approach is pre-
sented in Section 7.2. In the following section we present our first
approach for drug–drug interaction extraction.
4. Hybrid approach for drug–drug interactions extraction
(FBM–KBM)
Our hybrid approach for DDI extraction combines: (i) a feature-
based machine learning method and (ii) a kernel based method.
We tested both the union and the intersection of the results of each
method.
4.1. Feature-based machine learning method (FBM)
In this approach, the problem is modeled as a supervised binary
classification task. We used a SVM classifier to decide whether a
candidate DDI pair is an authentic DDI or not. We used the LibSVM
tool [3] to train a model using C-Support Vector Classification
(C-SVC) with the Radial Basis kernel function. The particular SVM
implementation (i.e. C-SVC SVM) and values of the associated
parameters are selected by doing experiments on a small subset
of the data. The set of features we used are described in Sections
4.1.1 and 4.1.2.
4.1.1. Features for DDI extraction
The following set of features was used to describe each candi-
date DDI pair (D1,D2):
 Word Features. Include words of D1, words of D2, words
between D1 and D2 and their number, three words before
D1, three words after D2 and lemmas of all these words.
 Morphosyntactic Features. Include Part-of-speech (POS)
tags of each drug word (D1 and D2), POS of the previous
three and next three words. We use TreeTagger 10 to obtain
lemmas and POS tags.
 Other Features. Include, among others, verbs between D1
and D2 and their number, first verb before D1 and first
verb after D2.
4.1.2. Advanced features
In order to improve the performance of our system, we used
lists of interacting drugs, constructed by extracting drug pairs that
are related by an interaction in the training corpus. We defined a
feature to represent the fact that candidate drug pairs are present
in this list.
However, such lists are not sufficient to identify an interaction
between new drug pairs. We also worked on detecting keywords
expressing such relations in the training sentences. The following
examples of positive (1,2) and negative (3) sentences show some
of the keywords or trigger words that may indicate an interaction
relationship.
1. The oral bioavailability of enoxacin is reduced by 60% with
coadministration of ranitidine.
2. Etonogestrel may interact with the following medications:
acetaminophen (Tylenol) . . .
3. There have been no formal studies of the interaction of
Levulan Kerastick for Topical Solution with any other drugs
. . .10 http://www.cis.uni-muenchen.de/schmid/tools/TreeTagger/.
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ing features:
 Trigger words. This category of features indicates whether
a specific trigger word (e.g. induce, inhibit) occurs in the
sentence. The trigger words were collected manually from
the training corpus.
 Negation. This category of features indicates if a negation
(e.g. not, no) is detected at a limited distance of characters
before, between and after the two considered drugs.
4.2. Kernel-based machine learning method (KBM)
In this approach, the DDI extraction task was addressed using a
system that exploits kernel-based method. Initially, the data had
been pre-processed to obtain relevant information on the tokens
in the sentences.
4.2.1. Data pre-processing
We used the Stanford parser11 [21] for tokenization, POS-tagging
and parsing of the sentences. The SPECIALIST lexicon tool12 was used
to normalize tokens to avoid spelling variations and also to provide
lemmas. The dependency relations produced by the parser were
used to create dependency parse trees for the corresponding
sentences.
4.2.2. System description
Our kernel-based system uses a composite kernel KSMP which
combines multiple tree and feature-based kernels. It is defined as
follows:
KSMPðR1;R2Þ ¼ KSLðR1;R2Þ þw1KMEDTðR1;R2Þ þw2KPSTðR1;R2Þ
where KSL;KMEDT and KPST represent respectively shallow linguistic
(SL) [16], mildly extended dependency tree (MEDT) [13] and PST
[28] kernels, and wi represents multiplicative constant(s). The val-
ues for all of the wi used during our experiments were equal to
1.13 The composite kernel is valid according to the kernel closure
properties.
A dependency tree (DT) kernel, pioneered by Culotta and Soren-
sen [15], is typically applied to the minimal or smallest common
subtree of a dependency parse tree that includes a target pair of
entities. Such subtree reduces unnecessary information by placing
word(s) closer to its dependent(s) inside the tree and emphasizes
local features of the corresponding relation. However, sometimes
a minimal subtree might not contain important cue words or pred-
icates. The MEDT kernel addresses this issue using some linguisti-
cally motivated expansions. We used the best settings for the
MEDT kernel reported by Chowdhury et al. [13] for protein–protein
interaction extraction.
The PST kernel is basically the path-enclosed tree (PET) pro-
posed by Moschitti [28]. This tree kernel is based on the smallest
common subtree of a phrase structure parse tree, which includes
the two entities involved in a relation.
The SL kernel is perhaps the best feature-based kernel used so
far for biomedical RE tasks (e.g. PPI and DDI extraction). It is a com-
bination of global context (GC) and local context (LC) kernels. The
GC kernel exploits contextual information of the words occurring
before, between and after the pair of entities (to be investigated11 http://nlp.stanford.edu/software/lex-parser.shtml.
12 http://lexsrv3.nlm.nih.gov/SPECIALIST/index.html.
13 Due to time constraints, we did not do tuning of the multiplicative constant(s)
(i.e. wi) during DDI-Extraction-2011. However, we did perform parameter tuning
using 5-fold cross-fold validation on the training data for DDI-Extraction-2013
which will be explained later.for RE) in the corresponding sentence; while the LC kernel exploits
contextual information surrounding individual entities.
The jSRE system14 is the implementation of these kernels using
the support vector machine (SVM) algorithm. It should be noted that,
by default, the jSRE system uses the ratio of negative and positive
examples as the value of the cost-ratio-factor15 parameter during
SVM training.
Segura-Bedmar et al. [35] used the jSRE system for DDI extrac-
tion on the same corpus (in the MMTx format) that has been used
during the DDI-Extraction-2011 challenge. They experimented
with various parameter settings, and reported as much as an F1
score of 0.6001. We used the same parameter settings (n-
gram = 3, window-size = 3) with which they obtained their best
result.
To compute the feature vectors of SL kernel, we used the jSRE
system. The tree kernels and composite kernel were computed
using the SVM-LIGHT-TK toolkit16 [29,19]. Finally, the ratio of neg-
ative and positive examples has been used as the value of the cost-
ratio-factor parameter.
5. Two-step approach for DDI detection and classification
Our second DDI extraction approach is basically a considerable
improvement (in terms of results obtained for DDI extractions) on
our hybrid approach described earlier. It performs DDI detection
and classification in two separate steps. We first present the DDI
detection method consisting in (i) discarding less informative sen-
tences, (ii) discarding less informative instances, and (iii) training
the system (a single model regardless of DDI types) on the remain-
ing training instances and identifying possible DDIs from the
remaining test instances.
5.1. Exploiting the scope of negations for sentence filtering
Negation is a linguistic phenomenon where a negation cue (e.g.
not) can alter the meaning of a particular text segment or of a fact.
This text segment (or fact) is said to be inside the scope of such
negation (cue). In one of our recent papers [11], we proposed an
approach to exploit the scope of negations for RE. We hypothesize
that a classifier trained solely on features related to the scope of
negations can be used to pro-actively filter groups of instances
which are less informative and mostly negative.
To bemore precise, we propose to train a classifier (whichwill be
appliedbefore using the kernel based RE classifiermentioned in Sec-
tion 5.3) that would check whether all the target entity mentions
inside a sentence along with possible relation clues (or trigger
words), if any, fall (directly or indirectly) under the scope of a nega-
tion cue. If such a sentence is found, then it would be identified as
less informative and discarded (i.e. the candidate mention pairs
inside such sentence would not be considered). During training
(and testing),we group the instances by sentences.Any sentence that
contains at least one relation of interest is considered by the Less Infor-
mative Sentence (LIS) classifier as a positive (training/test) instance.The
remaining sentences are considered as negative instances.
We use a number of features related to negation scopes to train
a binary SVM classifier that filters out less informative sentences
Chowdhury and Lavelli [11]. These features are basically contex-
tual and shallow linguistic features, and are described below:
 has2TM: The sentence has exactly 2 target entity mentions.14 http://hlt.fbk.eu/en/technology/jSRE.
15 This parameter value is the one by which training errors on positive examples
would outweigh errors on negative examples.
16 http://disi.unitn.it/moschitti/Tree-Kernel.htm.
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mentions.
 allTMonRight: All target entity mentions inside the sen-
tence appear after the negation cue.
 neitherAllTMonLeftOrRight: Some but not all target entity
mentions appear after the negation cue.
 negCue: The negation cue itself.
 immediateGovernor: The word on which the cue is directly
syntactically dependent.
 nearestVerbGovernor: The nearest verb in the dependency
graph on which the cue is syntactically dependent.
 isVerbGovernorRoot: The nearestVerbGovernor is root of the
dependency graph of the sentence.
 allTMdependentOnNVG: All target entity mentions are
syntactically dependent (directly/indirectly) on the
nearestVerbGovernor.
 allButOneTMdependentOnNVG: All but one target entity
mentions are syntactically dependent on the
nearestVerbGovernor.
 although⁄PrecedeCue: The syntactic clause containing the
negation cue begins with ‘‘although/ though/ despite/ in
spite”.
 commaBeforeNextTM: There is a comma in the text
between the negation cue and the next target entity
mention after the cue.
 commaAfterPrevTM: There is a comma in the text between
the previous target entity mention before the negation cue
and the cue itself.
 sentHasBut: The sentence contains the word ‘‘but”.
The objective of the classifier is to decide whether all target
entity mentions as well as any possible evidence inside the corre-
sponding sentence fall under the scope of a negation cue in such a
way that the sentence is unlikely to contain the relation of interest
(e.g. DDI). If the classifier finds such a sentence, it is assigned the
negative class label.
At present, we focus only on the first occurrence of the negation
cues ‘‘no”, ‘‘n’t” or ‘‘not”. These cues usually occur more frequently
and generally have larger negation scope than other negation cues.
The LIS classifier is trained using a linear SVM classifier. Its
hyper-parameters17 are tuned during training using 5-fold cross-
validation for obtaining maximum recall with a non-zero precision.
In this way we minimize the number of false negatives (i.e. sen-
tences that contain relations but are wrongly filtered out). Once
the classifier is trained using the training data, we apply it on both
the training and test data. However, if the recall of the LIS classifier
is found to be below a threshold value18 during cross validation on
the training data of a corpus, it is not used for sentence filtering
on such corpus.
Any (training/test) sentence that is classified as negative is con-
sidered as a less informative sentence and is filtered out. In other
words, such a sentence is not considered for RE. However, it should
be noted that, if such a sentence is a test sentence and it contains
positive RE instances, then all these filtered positive RE instances are
automatically considered as false negatives during the calculation of
RE performance.
We rule out sentences (i.e. we consider them neither positive
nor negative instances for training the classifier that filters less
informative sentences) during both training and testing if any of
the following conditions holds:17 (i) C: trade-off between training error and margin, and (ii) cost: cost-factor, by
which training errors on positive examples outweight errors on negative examples.
18 We set it to 70.0 which is chosen empirically. The sentence contains less than two target entity mentions
(such sentence would not contain the relation of interest
anyway).
 It has any of the following phrases – ‘‘not recommended”,
‘‘should not be” or ‘‘must not be”.19
 There is no ‘‘no”, ‘‘n’t” or ‘‘not” in the sentence.
 No target entity mention appears in the sentence after
‘‘no”, ‘‘n’t’ or ‘‘not”.
5.2. Discarding instances using semantic roles and contextual evidence
For identifying less informativenegative instances,weexploit static
(i.e. already known, heuristically motivated) and dynamic (i.e. auto-
matically collected from the data) knowledge which has been pro-
posed in [10]. This knowledge is described by the following criteria:
 C1: If each of the two entity mentions (of a candidate pair)
has anti-positive governors with respect to the type of the
relation, then they are not likely to be in a given relation.
 C2: If two entity mentions in a sentence refer to the same
entity, then it is unlikely that they would have a relation
between themselves.
 C3: If a mention is the abbreviation of another mention
(i.e. they refer to the same entity), then they are unlikely
to be in a relation.
Criteria C2 and C3 (static knowledge) are quite intuitive. For cri-
terion C1, we construct on the fly a list of anti-positive governors, to
be discussed below, taken from the training data and use them for
detecting pairs that are unlikely to be in relation. As for criterion
C2, we simply check whether two mentions have the same name
and there is more than one character between them. For criterion
C3, we look for any expression of the form ‘‘Entity1 (Entity2)” and
consider ‘‘Entity2” as an abbreviation or alias of ‘‘Entity1”.
The above criteria are used to filter instances from both training
and test data. Any positive test instance filtered out by these criteria is
automatically considered as a false negative during the calculation of
RE performance.
Anti-positive governors: The semantic roles of the entity men-
tions may indirectly contribute either to relate or not to relate
them in a particular relation type (e.g. PPI) in the corresponding
context. To put it differently, the semantic roles of two mentions
in the same context could provide an indication whether the rela-
tion of interest does not hold between them. Interestingly, the
word on which a certain entity mention is (syntactically) depen-
dent (along with the dependency type) could often provide a clue
of the semantic role of such mention in the corresponding sen-
tence. Our goal is to automatically identify the words (if any) that
tend to prevent mentions, which are directly dependent on those
words, from participating in a certain relation of interest with
any other mention in the same sentence. We call such words
anti-positive governors and assume that they could be exploited
to identify negative instances (i.e. negative entity mention pairs)
in advance. Below we describe our approach for the automatic
identification of such words.
Let EN be the set of entity mentions such that if eis 2 EN (where s
indicates the corresponding training sentence and i indicates the
corresponding entity mention index inside such sentence), then
eis does not have any relation of interest (i.e. PPI) with any other
mention inside the same sentence.
Let EP be the set of entity mentions such that if eks 2 EP (where s
indicates the corresponding training sentence and k indicates the19 These expressions often provide clues that one of the drug entity mentions
negatively influences the level of activity of the other.
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has at least one relation of interest with one of the mentions inside
the same sentence.
For example, consider the following sentence (taken from the
IEPA corpus) where there are three entity mention annotations –
oxytocin1, oxytocin2 and IP33.
These results indicate that oTP-1 may prevent luteolysis by inhibit-
ing development of endometrial responsiveness to oxytocin1 and,
therefore, reduce oxytocin2-induced synthesis of IP33 and PGF2
alpha.
Here, the mention oxytocin1 does not participate in any PPI rela-
tion in this sentence. So, it would be included in EN. The other two
mentions would be added to EP, because they are in PPI relation
with each other. Note that the two mentions of the entity oxytocin
are treated separately.
Now, let GV be the set of governor words where for each w 2 GV,
(i) there is at least one mention eis 2 EN which is syntactically
dependent on w in the corresponding training sentence s and (ii)
there is no mention eks 2 EP which is syntactically dependent on
w in the corresponding training sentence s. We call this set GV as
the list of anti-positive governors [10].
5.3. Hybrid kernel-based RE classifier
As RE classifier we use the following hybrid kernel that has been
proposed in [11]. It is defined as follows:
KHybrid ðR1;R2Þ ¼ KHF ðR1;R2Þ þ KSL ðR1;R2Þ þw  KPET ðR1;R2Þ:
where KHF is a feature based kernel that uses a heterogeneous set of
features, KSL is the Shallow Linguistic (SL) kernel proposed by Giu-
liano et al. [16], and KPET stands for the Path-enclosed Tree (PET)
kernel [28]. w is a multiplicative constant that allows the hybrid
kernel to assign more (or less) weight to the information obtained
using tree structures depending on the corpus. We exploit the
SVM-Light-TK toolkit [29,19] for kernel computation. The parame-
ters are tuned by doing 5-fold cross validation on the training data.
5.4. DDI type classification
The second step is to classify the extracted DDIs into different
categories. We train 4 separate models for each of the DDI types
(one vs all) to predict the class label of the extracted DDIs. During
this training, all the negative instances from the training data are
removed. The filtering techniques described in Sections 5.1 and
5.2 are not used in this stage.
Once the above models are trained, they are applied on the DDIs
extracted from the test data. The class label of the model which has
the highest confidence score for an extracted DDI instance is
assigned to such instance.
6. Experiments on the DDI-Extraction-2011 corpus
6.1. Dataset
The DDI-Extraction-2011 challenge20 required the automatic
identification of DDI from biomedical articles. Only the intra-
sentential DDI (i.e. DDI within single sentence boundaries) are
considered. The challenge corpus [35] is divided into training and
evaluation dataset. Initially released training data consist of 435
abstracts and 4267 sentences, and were annotated with 2402 DDI.
During the evaluation phase, a dataset containing 144 abstracts
and 1539 sentences was provided to the participants as the evalua-20 http://labda.inf.uc3m.es/DDIExtraction2011/.tion data. Both datasets contain drug annotations, but only the train-
ing dataset has DDI annotations.
These datasets are made available in two formats: the
so-called unified format and the MMTx format. The unified
format contains only the tokenized sentences, while the MMTx
format contains the tokenized sentences along with POS tag for
each token.
We used the unified format data. In both training and evalua-
tion datasets, there are some missing special symbols, perhaps
due to encoding problems. The position of these symbols can be
identified by the presence of the question mark ‘‘?” symbol. For
example:
hsentence id = ‘‘DrugDDI.d554.s14” origId = ‘‘s14” text = ‘‘Ergo-
tamine or dihydroergotamine?acute ergot toxicity characterized
by severe peripheral vasospasm and dysesthesia.”i6.2. Results using our hybrid approach FBM–KBM
We split the original development corpus into two parts: the
first part contains 63% of the documents (i.e. 276 docs) containing
around 67% of the ‘‘true” DDI pairs (i.e. 1603) and was used for tun-
ing the systems. The remaining documents belong to the second
part which was used as a test corpus for performance evaluation.
Both systems of the hybrid approach were trained and evaluated
using these splits of the development corpus (cf. Table 1 shows
their respective results).
The recall of the union (on the positive DDI) of the outputs of
each approach was higher than the individual output of the sys-
tems. We also calculated results for the intersection (only common
positive DDI) of the outputs which decreased the performance. It is
also important to note that the feature-based method (FBM)
reached higher precision while the kernel-based method (KBM)
obtained higher recall.
Table 2 shows the evaluation results for the proposed
approaches on the final challenge evaluation corpus. The union of
outputs of the systems has produced an F1 score of 0.6398which is
better than the individual results. The behavior of precision and
recall obtained by the two approaches is the same as observed
on the development corpus (better precision for the feature-
based approach and better recall for the kernel-based approach),
however, the F1 score of the kernel-based approach is quite close
(F1 score of 0.6365) to that of the union.6.3. Results using KHybrid (i.e. the 1st step of the two-step approach)
We used the KHybrid (which is used in the 1st step of our two-
step approach for DDI extraction) to do similar experiments on
the DDI-Extraction-2011 corpus. The results (see Table 3) show
that the more advanced linguistically informed KHybrid based RE
approach outperforms the hybrid approach which is the union of
KBM and FBM described before. In fact, the results of KHybrid are also
significantly better than the results of the best system in the
DDI-Extraction-2011 shared task.7. Experiments on the DDI-Extraction-2013 corpus
7.1. Dataset
The DDI-Extraction-2013 shared task includes two tasks:
 Task 9.1: Recognition and classification of drug names.
 Task 9.2: Extraction and Classification of drug–drug
interactions.
Table 1
DDI-Extraction-2011. Experimental results when trained on 63% of the original
training documents and tested on the remaining (FBM: Feature-Based Method, KBM:
Kernel-Based Method).
FBM KBM Union Intersection
Precision 0.5910 0.4342 0.4218 0.6346
Recall 0.3640 0.5277 0.6083 0.2821
F1 score 0.4505 0.4764 0.4982 0.3906
Bold value correspond to the best results.
Table 2
DDI-Extraction-2011. Evaluation results provided by the challenge organizers (FBM:
Feature-Based Method, KBM: Kernel-Based Method).
FBM KBM Union
True positive 319 513 532
False positive 133 344 376
False negative 436 242 223
True negative 6138 5927 5895
Precision 0.7058 0.5986 0.5859
Recall 0.4225 0.6795 0.7046
F1 score 0.5286 0.6365 0.6398
Bold values correspond to the best results.
Table 3
DDI-Extraction-2011. Comparison of results on the official test set using the hybrid
approach and the KHybrid kernel based RE approach.
P R F1 score
Hybrid approach (i.e. union of KBM and FBM) 0.5859 0.7046 0.6398
Proposed KHybrid 0.6001 0.7432 0.6640
Bold values correspond to the best results.
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(i) 233 MedLine abstracts on drug–drug interactions and (ii) 784
documents describing drug–drug interactions from the DrugBank
database, in order to deal with different types of texts and lan-
guage styles. The corpus is annotated with drug–drug interactions
and pharmacological substances.
Participants were asked to not only extract DDI but also classify
them into one of four pre-defined classes: advise, effect, mech-
anism and int. A detailed description of the task settings and data
can be found in [33]. Evaluation results are reported using the stan-
dard Precision, Recall and F1 score metrics.
7.2. Task 9.1: Recognition and classification of drug names
The first task21 focuses on the extraction and classification of four
types of pharmacological entities:
 Drug is any chemical entity that is used for treatment,
diagnosis of disease, prevention or cure and is approved
for human use.
 Brand is any drug that was developed firstly by a pharma-
ceutical company.
 Group is any term that describes a chemical or pharmaco-
logical relationship of drugs.
 Drug_n is any active substance that has not been approved
for human use.
The organizers of the task proposed several matching criteria
for the evaluation of the results, which are:
 Strict evaluation: correct mentions must have the correct
start offset and end offset as well as the correct entity type.
 Type matching: correct mentions can overlap the refer-
ence mentions if they have the correct entity type.
 Exact boundary matching: correct mentions must have
the same start and end offsets of the reference mentions,
regardless of the entity type (used to evaluate strict
boundary detection).21 http://www.cs.york.ac.uk/semeval-2013/task9/data/uploads/task-9.1-drug-ner.
pdf. Partial boundary matching: correct mentions must have
an overlap with the reference mentions, regardless of the
entity type (used to evaluate partial boundary detection).
We use different combinations of the features and two different
tools for annotating the words with their part-of-speech tags (POS-
tags) and lemma.
 Run 1: All the linguistic and token features (see Sec-
tion 3.2) as well as the features for annotating the words
as stop words, abbreviations and medical units of mea-
surement are used. TreeTagger22 is used for annotating
the words with part-of-speech and lemma information.
 Run 2: Uses the features of the first run and the Stan-
fordTagger23 tool for estimating the boundaries of words,
their lemma and their part-of-speech tags instead of
TreeTagger (used in the first run).
 Run 3: Uses the features of the second run with a feature
for annotating the words in the BIO format of the Drug
class, using lists of drug names.
 Run 4: Uses all the features of the third run and a feature
for annotating the words in the BIO format of the Ingredi-
ent class using a list of drugs’ ingredients.
Table 4 presents the results according to the four criteria. The F1
score obtained for run 1 is 0.69 for partial matching and this score
slightly decreased to 0.67 for exact matching in the Drugbank and
Medline datasets. This means that most of the tagged mentions of
our system have the correct start and end offset. F1 score decreases
when the system checks the entity type (0.64 F1 for type matching)
and for exact boundaries (0.58 F1 for strict matching).
In Run 2, we use the StanfordTagger instead of TreeTagger for
finding the mentions boundaries as well as their part-of-speech
tags and their lemmas. The F1 scores corresponding to exact and
partial boundary matching slightly increased by 0.01 point overall.
For the Drugbank dataset the F1 score for the exact and partial
boundariesmatching increased respectively by +0.3 and +0.4. These
results suggest that StanfordTagger identifies the boundaries of the
mentions more effectively than TreeTagger. The final F1 scores for
strict matching and type matching has therefore also increased by
+0.02 points overall and by +0.05 points on the Drugbank dataset.
In Run 3, the F1 scores for strict and type matching are slightly
better than the scores of Run 2 with a +0.02 increase on both
benchmarks. This may be explained by the addition of lists of drug
names for annotation of the words with the BIO tags for the Drug
class. The F1 scores for the partial and exact boundaries matching
remained stable as expected.
In Run 4, the F1 score of strict and type matching are higher
than those of Run 3. More precisely, F1 scores for strict evaluation
slightly increased from 0.62 to 0.63 and the F1 score for type
matching increased from 0.68 to 0.69. As the names of the ingredi-
ents can be related to the names of drugs, the CRF algorithm had an
additional clue to predict more effectively whether a word belongs
to a drug name or not.22 http://www.cis.uni-muenchen.de/schmid/tools/TreeTagger.
23 http://nlp.stanford.edu/software/tagger.shtml.
Table 4
DDI-Extraction-2013 Task 9.1. Results according to different criteria.
Criteria Run DrugBank and MedLine MedLine DrugBank
P R F P R F P R F
Strict evaluation 1 0.78 0.46 0.58 0.7 0.23 0.35 0.9 0.59 0.71
2 0.79 0.48 0.6 0.74 0.25 0.37 0.91 0.64 0.76
3 0.83 0.49 0.62 0.73 0.24 0.36 0.93 0.65 0.77
4 0.85 0.5 0.63 0.73 0.24 0.36 0.93 0.7 0.8
Type matching 1 0.86 0.51 0.64 0.82 0.27 0.41 0.96 0.63 0.76
2 0.88 0.53 0.66 0.86 0.29 0.44 0.97 0.69 0.81
3 0.9 0.54 0.68 0.86 0.28 0.43 0.99 0.69 0.81
4 0.93 0.54 0.69 0.86 0.28 0.42 0.98 0.74 0.84
Exact boundary matching 1 0.9 0.53 0.67 0.87 0.29 0.43 0.93 0.61 0.73
2 0.89 0.54 0.68 0.86 0.29 0.44 0.91 0.64 0.76
3 0.91 0.54 0.68 0.86 0.28 0.42 0.94 0.66 0.78
4 0.91 0.53 0.67 0.85 0.27 0.42 0.95 0.71 0.81
Partial boundary matching 1 0.9 0.56 0.69 0.87 0.31 0.46 0.93 0.63 0.75
2 0.89 0.57 0.7 0.86 0.32 0.46 0.93 0.68 0.79
3 0.91 0.57 0.7 0.86 0.3 0.45 0.94 0.68 0.79
4 0.91 0.56 0.69 0.85 0.3 0.44 0.95 0.73 0.83
Bold values correspond to the best results.
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for each entity type (Drug, Brand, Group and Drug_n). According
to these results, our system for drug name recognition predicted
correctly entities of type ‘‘Brand” with 0.92 F1 score and the entity
of type ‘‘Drug” with 0.72 F1 score. Our system is less effective for
predicting the Group entities (0.63 F1 score) than the Brand or
Drug types. It also failed to identify the words that are related to
Drug_n entities. This last aspect may be caused by the absence of
relevant features for chemical compounds (e.g. features based on
the ChEBI24 dictionary, which will be added in coming work).
Table 6 represents themacro-average F1 score computed over all
entity types. It shows that Run 3 is the most effective configuration
for drug name recognition among the 4 runs overall and for the
DrugBank dataset. Run 2 is the most effective run for identifying
pharmaceutical substances in the MedLine dataset. It is also
observed that the highest score for allmetrics is obtained on theDrug-
Bank dataset. Actually, the MedLine dataset contains only abstracts
and has therefore fewer medical texts than the DrugBank dataset
which usually containmore details and cues to recognize drug names.
Overall, our method based on Conditional Random Fields (CRFs)
combined with linguistic and semantic features reached a macro-
average F1 score of 0,57. Grego et al. [17] achieved almost the same
score (0.577 F1) as ours. They used CRFs combined with linguistic
features and database annotations. They also used a resolution
method that takes as input the annotated named entities and pro-
vides themost relevant ChEBI terms from the ChEBI ontology. Rock-
täschel et al. [31] achieved the best F1 score (0.652) in the DDI-
Extraction-2013 task. They constructed a named entity recognition
system using CRFs combined with linguistic features and semantic
features derived from Jochem, PHARE and ChEBI ontologies.
7.3. Task 9.2: Extraction and classification of drug–drug interactions
The second task25 focuses on the extraction and classification of
DDI. As reported by the organizers in the task description paper [33],
the results obtained by our system for both DDI extraction and clas-
sification are significantly higher than all the other participants in
the shared task.
The task 9.2 data include two types of texts: texts taken from
the DrugBank database and texts taken from MedLine abstracts.
During training we used both types of text together.24 http://www.ebi.ac.uk/chebi/downloadsForward.do.
25 http://www.cs.york.ac.uk/semeval-2013/task9/data/uploads/task-9.2-ddi-extrac-
tion.pdf.The Charniak–Johnson reranking parser [4], along with a self-
trained biomedical parsing model [27], has been used for tokeniza-
tion, POS-tagging and parsing of the sentences. Then the parse
trees are processed by the Stanford parser [21] to obtain syntactic
dependencies. The Stanford parser often skips some syntactic
dependencies in output. We use the rules proposed in [9] to
recover some of such dependencies. We use the same techniques
for unknown characters (if any) as described in [8].
Our system uses the SVM-Light-TK toolkit26 [29,19] for compu-
tation of the hybrid kernels. The ratio of negative and positive exam-
ples has been used as the value of the cost-ratio-factor parameter.
The SL kernel is computed using the jSRE tool.27
The KHF kernel can exploit non-target entities to extract impor-
tant clues [11]. So, we use a publicly available state-of-the-art NER
system called BioEnEx [7] to automatically annotate both the train-
ing and the test data with disease mentions.
Table 7 shows the results of 5-fold cross validation for DDI
detection on the training data. As we can see, the usage of the
LIS and LII filtering techniques improves both precision and recall.
We submitted three runs for the DDI-Extraction-2013 shared
task. The only difference between the three runs concerns the
default class label (i.e. the class chosen when none of the separate
models assigns a class label to a predicted DDI). Such default class
label is int, effect and mechanism for run 1, 2 and 3 respec-
tively. According to the official results provided by the task orga-
nizers, our best result was obtained by run 2 (shown in Table 8).
According to the official results, the performance for advise is
very low (F1 0.29) in MedLine texts, while the performance for int
is comparatively much higher (F1 0.57) with respect to the one of
the other DDI types. In comparison, the performance for int is
much lower (F1 0.55) in DrugBank texts with respect to the one
of the other DDI types.
In MedLine test data, the number of effect (62) and mecha-
nism (24) DDIs is much higher than that of advise (7) and int
(2). On the other hand, in DrugBank test data, the different DDIs
are more evenly distributed – effect (298), mechanism (278),
advise (214) and int (94).
Initially, it was not clear to us why our system (as well as other
participants) achieves so much higher results on the DrugBank
sentences in comparison to MedLine sentences. Statistics of the
average number of words show that the length of the two types26 http://disi.unitn.it/moschitti/Tree-Kernel.htm.
27 http://hlt.fbk.eu/en/technology/jSRE.
Table 5
DDI-Extraction-2013 Task 9.1. Results according to each entity type (Drug, Brand, Groups and Drug_n).
Entity type Run DrugBank and MedLine MedLine DrugBank
P R F P R F P R F
Drug 1 0.86 0.58 0.69 0.8 0.43 0.56 0.92 0.62 0.74
2 0.85 0.6 0.7 0.83 0.48 0.61 0.91 0.65 0.76
3 0.87 0.6 0.71 0.79 0.46 0.58 0.94 0.65 0.77
4 0.9 0.61 0.72 0.81 0.45 0.58 0.94 0.72 0.82
Brand 1 0.98 0.68 0.8 0 0 0 0.97 0.64 0.77
2 1 0.76 0.87 0 0 0 1 0.79 0.88
3 1 0.85 0.92 0 0 0 1 0.87 0.93
4 0.98 0.86 0.92 0 0 0 1 0.87 0.93
Group 1 0.83 0.45 0.59 0.87 0.14 0.25 0.85 0.51 0.63
2 0.85 0.48 0.62 0.76 0.14 0.24 0.88 0.57 0.69
3 0.86 0.5 0.63 0.75 0.13 0.23 0.88 0.55 0.68
4 0.86 0.5 0.63 0.75 0.13 0.23 0.88 0.57 0.69
Drug_n 1 0 0 0 1 0.01 0.02 0 0 0
2 0 0 0 1 0.01 0.02 0 0 0
3 0 0 0 1 0.01 0.02 0 0 0
4 0 0 0 1 0.01 0.02 0 0 0
Bold values correspond to the best results.
Table 6
DDI-Extraction-2013 Task 9.1. Macro-average measures for each run.
Run DrugBank and
MedLine
MedLine DrugBank
P R F P R F P R F
1 0.67 0.43 0.52 0.67 0.15 0.21 0.68 0.44 0.54
2 0.68 0.46 0.55 0.65 0.16 0.22 0.7 0.5 0.58
3 0.68 0.49 0.56 0.63 0.15 0.21 0.7 0.52 0.59
4 0.68 0.49 0.57 0.64 0.15 0.21 0.71 0.54 0.61
Bold values correspond to the best results.
Table 8
DDI-Extraction-2013 Task 9.2. Official results of the best run of our system (run 2).
P R F1
All text
DDI detection only 0.79 0.81 0.80
Detection and classification 0.65 0.66 0.65
DrugBank text
DDI detection only 0.82 0.84 0.83
Detection and classification 0.67 0.69 0.68
MedLine text
DDI detection only 0.56 0.51 0.53
Detection and classification 0.42 0.38 0.40
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MedLine: 22.3). It is true that the number of the training sentences
for the former is almost 5.3 times higher than the latter. But it
could not be the main reason for such high discrepancies.
So, we turned our attention to the presence of the cue words. In
the 4,683 sentences of the DrugBank training set (which have at
least one drug mention), we found that the words ‘‘increase” and
‘‘decrease” are present in 721 and 319 sentences respectively. On
the other hand, in the 877 sentences of the MedLine training set
(which have at least one drug mention), we found that the same
words are present in only 67 and 40 sentences respectively. In
other words, the presence of these two important cue words in
the DrugBank sentences is twice more likely than that in the Med-
Line sentences. We assume similar observations might be also pos-
sible for other cue words. Hence, this is probably the main reason
why the results are so much better on the DrugBank sentences.
8. Discussion and future work
Our approach to drug name recognition obtained encouraging
results with respect to systems participating in the shared task of
DDI-Extraction-2013, especially considering that we made the
choice to use only publicly available lists as semantic features,
without relying on unavailable (ad hoc) tools or ontologies. InTable 7
DDI-Extraction-2013 Task 9.2. Comparison of results for DDI detection on the training
data using 5-fold cross validation. Parameter tuning is not done during these
experiments.
P R F1
KHybrid 0.66 0.80 0.72
LIS filtering + KHybrid 0.67 0.80 0.73
LIS filtering + LII filtering + KHybrid 0.68 0.82 0.74
Bold values correspond to the best results.future work we are considering to test the impact of annotations
from open-domain ontologies like DBpedia or YAGO when used
as features in the drug name recognition process.
For DDI extraction we studied the combination of Feature-
Based Methods (FBM) and Kernel-Based Methods (KBM). Our
hybrid system was ranked second in the DDI-Extraction-2011 task.
The results show that the KBM outperformed the FBM. We also
observed that the union of results of both methods led only to
slight improvement of 0.0033 w.r.t. KBM according to F1 score.
The results obtained by the combination of FBM and KBM and
the fact that the precision of the FBM was 11% higher than KBM
(cf. Table 2) suggest that the DDIs found only by the FBM are
mostly incorrect, i.e. that the KBM already found most of the cor-
rect DDIs that were retrieved by the FBM. Therefore, the logical
track of enhancement would rather be to use a method that helps
identifying the false positives retrieved by the KBM.
We significantly improved our technique for DDI extraction by
developing a high performance hybrid kernel, KHybrid, and extended
extraction to DDI classification (i.e. our two-step approach). This
state-of-the-art approach outperformed the results obtained by
all the other participating teams in the DDI-Extraction-2013
shared task by a wide margin.
In future work, we will study the performance of these different
methods for the detection of Adverse Drug Reactions (ADR), which
is one of the priority areas considered by the World Health Organi-
zation (2002).28 We will particularly address two main challenges to
text mining for pharmacovigilance:28 http://apps.who.int/iris/bitstream/10665/42493/1/a75646.pdf?ua=1.
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sources of information about pharmacovigilance that con-
tain a huge amount of data and provide complementary
knowledge (e.g. scientific papers, forums, social networks,
linked data).
 Personalization according to the patient profile. Reactions
of patients to drugs can be very different. We think that it
is crucial to include patient characteristics in the analysis
process, whether by model-based inference or feature-
based learning.
9. Conclusion
Text mining can be an efficient and scalable solution for the
analysis of medical corpora such as scientific articles or clinical
records in order to understand and support pharmacovigilance.
This paper reported our experiments on text mining techniques
for the extraction and classification of drugs and drug–drug
interactions.
We presented our hybrid method for DDI extraction that com-
bines two different machine learning methods to extract DDI: (i)
a feature-based method that uses a SVM classifier with a set of lex-
ical, morphosyntactic and semantic features and (ii) a kernel-based
method that uses a kernel which is a composition of a mildly
extended dependency tree kernel, a phrase structure tree kernel,
and a shallow linguistic kernel. We participated in the DDI-
Extraction-2011 challenge and we obtained 0.6398 F1 score, the sec-
ond best results in the shared task.
For drug name recognition, we presented our feature-based
method that identifies and classifies drugs into four classes. We
evaluated our method on the Drug recognition corpus of the DDI-
Extraction challenge at SemEval 2013 and obtained encouraging
results: 0.57 F1 score on all texts and 0.61 F1 score on the Drug-
Bank corpus.
Finally, we presented our two-step approach for the detection
and classification of DDI. Our approach outperformed all the other
participating teams in the DDI Detection and Classification task at
SemEval 2013 with 0.80 F1 score for detection only and 0.658 F1
score for detection and classification. The central component of
the proposed approach is a state-of-the-art hybrid kernel. Our
approach also exploits the scope of negation cues and the semantic
roles of the involved entities.
The three systems described in this paper and the three available
corpora used to train and evaluate our systems represent a first step
towards supporting pharmacovigilance through text mining. Nev-
ertheless, more information should be taken into account such as
patient characteristics (e.g. age, history of diseases and drugs) and
more document sources should be explored. In future work, we
plan to exploit data integration techniques in order to use different
sources of information (e.g. articles, websites, linked data). We also
plan to develop NLP techniques adapted to each information source
for the recognition of drugs, side effects, information about patients
and for the extraction of DDI and other relations between drugs and
side effects. Future work will include also the design and develop-
ment of a web service that incorporates our three systems, with
online annotation and visualization components.
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